These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Two-stage phase II oncology designs using short-term endpoints for early stopping. Kunz CU; Wason JM; Kieser M Stat Methods Med Res; 2017 Aug; 26(4):1671-1683. PubMed ID: 26037529 [TBL] [Abstract][Full Text] [Related]
33. Sample size calculation for randomized selection trials with a time-to-event endpoint and a margin of practical equivalence. Dehbi HM; Embleton-Thirsk A; McCaw ZR Stat Med; 2022 Sep; 41(20):4022-4033. PubMed ID: 35688463 [TBL] [Abstract][Full Text] [Related]
34. Group sequential adaptive designs in series of time-to-event randomised trials in rare diseases: A simulation study. Bayar MA; Le Teuff G; Koenig F; Le Deley MC; Michiels S Stat Methods Med Res; 2020 Jun; 29(6):1483-1498. PubMed ID: 31354106 [TBL] [Abstract][Full Text] [Related]
35. Randomized phase II trials: a long-term investment with promising returns. Sharma MR; Stadler WM; Ratain MJ J Natl Cancer Inst; 2011 Jul; 103(14):1093-100. PubMed ID: 21709274 [TBL] [Abstract][Full Text] [Related]
36. Interval and point estimation in adaptive Phase II trials with binary endpoint. Nhacolo A; Brannath W Stat Methods Med Res; 2019 Sep; 28(9):2635-2648. PubMed ID: 29921157 [TBL] [Abstract][Full Text] [Related]
37. Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpoints. Kakizume T; Zhang F; Kawasaki Y; Daimon T Pharm Stat; 2020 Jan; 19(1):71-83. PubMed ID: 31496045 [TBL] [Abstract][Full Text] [Related]
38. Study design of single-arm phase II immunotherapy trials with long-term survivors and random delayed treatment effect. Chu C; Liu S; Rong A Pharm Stat; 2020 Jul; 19(4):358-369. PubMed ID: 31930622 [TBL] [Abstract][Full Text] [Related]
39. Optimal two-stage designs for single-arm phase II oncology trials with two binary endpoints. Kunz CU; Kieser M Methods Inf Med; 2011; 50(4):372-7. PubMed ID: 21057719 [TBL] [Abstract][Full Text] [Related]
40. Randomized phase II clinical trials. Simon R; Wittes RE; Ellenberg SS Cancer Treat Rep; 1985 Dec; 69(12):1375-81. PubMed ID: 4075313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]